I call our meeting to order.
Welcome to meeting number 62 of the health committee. We are going to continue our study on antimicrobial resistance. We have four groups of witnesses today, so we will have four opening statements. They are going to be limited to 10 minutes, and I am going to be very tough today. I hate interrupting people, but I may have to if you go over 10 minutes, because we're tight on time.
I'll introduce our guests. Thank you very much for coming.
Dr. Andrew Morris is chair of the antimicrobial stewardship and resistance committee of the Association of Medical Microbiology and Infectious Disease Canada. From the Canadian Nurses Association, we have Karey Shuhendler, policy adviser for policy, advocacy, and strategy, and Yoshiko Nakamachi, antimicrobial resistance nursing expert. From the Canadian Pharmacists Association, we have Shelita Dattani, director of practice development and knowledge translation. From the Royal College of Physicians and Surgeons, we have Dr. Michael Routledge, medical officer of health, Southern Health regional health authority.
We are going to start with the Association of Medical Microbiology and Infectious Disease. Dr. Morris, you have 10 minutes.